TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: CTX-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PINP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of hypoxemia
Endpoint domain: Adverse events/effects
Primary endpoint: bronchoscopist satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: intervention completion
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: intervention satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: contraception consultation visit attendance
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: waste separation behavior
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Pain Interference
Endpoint domain: Life impact
Endpoint subdomain: Pain Interference
Primary endpoint: self-reported salt intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum CRP level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total bilirubin level reduction after 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total bilirubin level reduction after 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ED symptoms post treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: end‐of‐treatment global functioning
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: reduction of radiation dose and contrast amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of IPSS Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in Men's Sexual Health Questionnaire - Ejaculatory Dysfunction (MSHQ-EjD)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean differences in relative light units on the face shield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cerebral Performance Category (CPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: time to achieve AW control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: absolute reduction of hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-complete Response (non-CR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade III toxicity incidence
Endpoint domain: Adverse events/effects
Primary endpoint: time to get symptom-free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to radiologic union
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NT-proBNP improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NYHA functional classification changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: CSA of the ulnar nerve reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: tolerance rate
Endpoint domain: Adverse events/effects
Primary endpoint: Cost-effectiveness of antibacterial envelope
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction of CIED infections
Endpoint domain: Adverse events/effects
Primary endpoint: 9HPT score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Olfactory function measured by Taiwan Smell Identification Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: semantic and morphosyntactic development
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular surface C. trachomatis load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Difference between planned versus achieved stromal thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of cTBS
Endpoint domain: Adverse events/effects
Primary endpoint: Trail Making Test Part B (TMT-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global WM fractional anisotropy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: radial diffusivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: WM volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical effective rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Swallowing scores of Fujishima Ichiro
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SWAL-QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Salivary cortisol levels following a social stress test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total visibility score (TVS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to resume physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean dose of opioid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TOMM performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CVLT‐II Forced Choice Recognition performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: CVLT‐II Short Delay Free Recall performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Plasma SPT‐07A concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of primary outcome associated with NT-proBNP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time taken to complete the operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median time to PG recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postprandial TG-AUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean decrease of NRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complications (frozen shoulders)
Endpoint domain: Adverse events/effects
Primary endpoint: Interference with mood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative deep sternal wound infections
Endpoint domain: Adverse events/effects
Primary endpoint: 14-day clinical controlled discharge rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Opioid use in recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of readability of patient information leaflets
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Presentation of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: final crest width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of clinically significant asthma exacerbations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pre‐bronchodilator FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ACQ‐5 and SGRQ scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of successfully amplified SSR markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood glucose levels/glycemic control
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incidence of hyperglycemic crises
Endpoint domain: Adverse events/effects
Primary endpoint: Enrollment in ImmPRINT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Awareness of IIS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge and attitudes toward IIS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increase of 1 or more CSBMs from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Proportion of participants having 3 or more CSBMs per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decrease of PAC-QOL score after 8 weeks of treatment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mean total abdominal drain volume on POD1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean total abdominal drain volume on POD2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean time for removal of all abdominal drains
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Risk of colorectal cancer at 10 years
Endpoint domain: Mortality/survival
Primary endpoint: Risk of death from colorectal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Infusion reactions (IRs)
Endpoint domain: Adverse events/effects
Primary endpoint: body fat mass reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hospitalisations within 1 month
Endpoint domain: Mortality/survival
Primary endpoint: cumulative incidence of radiological recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative incidence of kidney cancer death
Endpoint domain: Mortality/survival
Primary endpoint: initial treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sedentary behavior reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body fat percentage reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: working memory precision judgements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C0–C2 axial rotation test reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean UCROM to the most restricted side
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SCHNOC-C score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SCHNOS-O score difference
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Volume of blood loss treated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: oral burning sensations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in pVO2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Use of alcohol protective strategies
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: motivation to exert oneself
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: progressed function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Improvements in functioning
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reductions in days lost
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Reduction in indirect costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: reduction of work-distaste-related burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of client-related burnout
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: reduction of anxiety and stress scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Transition from 'not healthy' to 'healthy' gingival case status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of appetite
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in CPM magnitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LS-PGA improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: coefficient of variation of rotational alignment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of anterior knee pain
Endpoint domain: Adverse events/effects
Primary endpoint: Adherence to proposed feeding method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in resting-state connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in food scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cross-protection against HPV31/33/45
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Non-inferiority of antibody responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: CBMpW > 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PAC-QoL improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of patients off insulin therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: VPI (Volunteers' Performance Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GBI (General Burden Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms of fibromyalgia syndrome (FMS)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: muscle activation in the hamstring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: muscle coactivation of the tibialis anterior and peroneus longus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ankle eversion angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Strong acceptance of periodical vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Compliance intentions levels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tandem stand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in VISA-Patella (VISA-P) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of sessions viewed
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increased healthcare costs associated with visual capacity deficit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increased healthcare costs associated with locomotor impairment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Increased healthcare costs associated with psychological impairment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Visual working memory (WM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verbal short-term memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Math fluency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biochemically verified abstinence at 6 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: GOS-E score at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PPIUD counseling rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Choice of PPIUD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement of OHRQoL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in hs-CRP and IL-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Participation in meaningful activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Cost-effectiveness at $100,000/QALY threshold
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Incidence of febrile urinary tract infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: favorable six-month GOSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of the nomogram for predicting risk of malignancy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HCW hand hygiene compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech motor control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speech articulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: word-level speech intelligibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NAR score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aspirated mean mass of mucus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean ratings for visualization attributes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in ultrasound measured fascia thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary exosomal protein leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: reductions in internalizing and externalizing symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of surgeon head turns to view the fluoroscopic monitor
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral transit time (OTT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Penetration‐Aspiration Scale (PAS) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax, ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability of the RealRisks web-based decision aid
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in knowledge about breast cancer risk and chemoprevention options
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Informed decision about chemoprevention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in ASD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sleep troubles
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: LVESVI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: medical expenses
Endpoint domain: Resource use
Primary endpoint: X-ray referral odds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: low back pain-specific disability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 'stand on one leg' test performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diastolic ARV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: systolic ARV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: improvements in mood
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median central nervous system equilibrium half-life times
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Areas under the curve of the logistic regression model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of exceeding low-risk drinking levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fine coordinated finger movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Odds ratio for losing 5% weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of diffusion capacity predicted (DLCO%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of total lung capacity predicted (TLC%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: St. George Respiratory questionnaire (SGRQ) scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Frequency of occurrence in State 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dwell time in State 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Severity of dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 6-year progression-free survival rate
Endpoint domain: Mortality/survival
Primary endpoint: Total volume of obturation material
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes